- Report
- October 2024
- 193 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- February 2025
- 240 Pages
Global
From €2457EUR$2,690USD£2,101GBP
- Report
- February 2025
- 90 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- April 2025
- 93 Pages
Global
From €5343EUR$5,850USD£4,569GBP
- Report
- April 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- April 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- November 2024
- 242 Pages
Global
From €2238EUR$2,450USD£1,913GBP
- Report
- January 2025
- 135 Pages
Global
From €2739EUR$2,999USD£2,342GBP
- Report
- May 2024
- 140 Pages
Global
From €5936EUR$6,499USD£5,076GBP
- Clinical Trials
- December 2024
- 240 Pages
Global
From €2740EUR$3,000USD£2,343GBP
- Report
- July 2024
- 200 Pages
Global
From €4520EUR$4,949USD£3,865GBP
- Report
- January 2025
- 182 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- September 2024
- 135 Pages
North America
From €3151EUR$3,450USD£2,694GBP
- Report
- September 2024
- 139 Pages
Middle East, Africa
From €3151EUR$3,450USD£2,694GBP
- Report
- September 2024
- 150 Pages
Europe
From €3151EUR$3,450USD£2,694GBP
- Report
- September 2024
- 146 Pages
Asia Pacific
From €3151EUR$3,450USD£2,694GBP
- Report
- October 2024
- 186 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- November 2024
- 150 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- May 2024
- 133 Pages
Global
From €5936EUR$6,499USD£5,076GBP
- Report
- June 2024
- 200 Pages
Global
From €7261EUR$7,950USD£6,209GBP

The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates.
Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more